| | | 债券代码：175781 债券简称：21 中化 G1 债券代码：185229 债券简称：22 中化 G1 债券代码：138949 债券简称：23 中化 K1 中化国际（控股）股份有限公司 关于召开2023年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 投资者可于 2023 年 09 月 04 日(星期一)16:00 前登录上证路演中心网 站首页点击"提问预征集"栏目或通过公司邮箱 600500@sinochem.com 进 行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 中化国际（控股）股份有限公司（以下简称"公司"）将于 2023 年 8 月 31 日发布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年半年度经营成果、财务状况，公司计划于 2023 年 09 月 05 日 上午 10:00- 11:00 举行 2023 年半年度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开，公司 ...

| | | 债券代码：175781 债券简称：21 中化 G1 债券代码：188412 债券简称：中化 GY01 债券代码：185229 债券简称：22 中化 G1 债券代码：138949 债券简称：23 中化 K1 中化国际（控股）股份有限公司 关于参加中国中化控股有限责任公司下属上市公司 2022年度暨2023年第一季度集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 问题征集：投资者可于 2023 年 5 月 11 日(星期四)16:00 前登录上证 路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 600500@sinochem.com 进行提问。公司将在说明会上对投资者普遍关注的问 题进行回答。 中化国际（控股）股份有限公司（以下简称"公司"）已于 2023 年 4 月 28 日发布公司 2022 年年度报告和 2023 年一季度报告。为便于广大投资者更全面、 更深入地了解中国中化控股有限责任公司（以下简称"中国中化"）所属上市公 司，同时以更为丰富、便捷的形式与投资者进 ...

Financial Performance - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 117.73% due to the current downturn in the chemical industry and intensified competition, resulting in lower prices and overall performance constraints [4]. - Basic earnings per share fell by 78.57% to CNY 0.03, reflecting significant declines in profitability [12]. - The net profit attributable to shareholders was CNY 112,963,352.98, a decrease of 71.33% compared to the same period last year [22]. - Total operating revenue for Q1 2023 was $14.77 billion, a decrease of 21.5% compared to $18.84 billion in Q1 2022 [42]. - Net profit for Q1 2023 was $194.01 million, a decline of 69.9% from $645.25 million in Q1 2022 [46]. - Total comprehensive income for the first quarter of 2023 was CNY 268,377,886.56, a decrease from CNY 672,075,835.44 in the same period of 2022 [48]. - Net profit attributable to the parent company was CNY 193,859,350.71, down from CNY 430,553,474.96 year-over-year [48]. Assets and Liabilities - Total assets decreased by 17.08% from the end of the previous year, amounting to CNY 58,256,731,057.64 [12]. - The company's total assets decreased to ¥58,256,731,057.64 from ¥70,257,205,941.45, a decline of about 17.1% [31]. - Total liabilities decreased to ¥33,331,334,480.71 from ¥43,714,263,487.29, a reduction of approximately 23.7% [31]. - The company's total liabilities decreased to $20.41 billion in Q1 2023, down from $24.78 billion in Q1 2022, indicating a reduction of 17.6% [42]. - The company's total equity decreased to ¥24,925,396,576.93 from ¥26,542,942,454.16, indicating a decline of about 6.1% [31]. - The total equity attributable to shareholders increased by 3.56% to CNY 18,790,102,260.17 compared to the end of the previous year [12]. Cash Flow - The company reported a net cash flow from operating activities of CNY 137,589,452.19, indicating a significant improvement compared to the previous year [22]. - Cash inflow from operating activities totaled CNY 15,905,771,868.65, a decline from CNY 19,567,889,448.48 in the previous year [51]. - Net cash flow from operating activities was CNY 137,589,452.19, a significant improvement from a net outflow of CNY -974,721,203.68 in Q1 2022 [51]. - The ending balance of cash and cash equivalents was CNY 2,688,421,113.23, down from CNY 4,274,265,454.06 at the end of Q1 2022 [53]. - The company's cash and cash equivalents decreased to ¥3,420,188,280.55 from ¥4,585,177,321.05 as of December 31, 2022, reflecting a decline of approximately 25.4% [30]. Operational Efficiency - The company aims to enhance operational efficiency and improve cash flow management in response to current market challenges [16]. - The weighted average return on net assets decreased by 2.71 percentage points to 0.60% [12]. - The company reported a decrease in cash received from sales of goods and services, totaling CNY 15,505,554,689.79, compared to CNY 19,134,147,346.03 in the previous year [51]. - The company's cash outflow for employee compensation increased to CNY 1,127,197,329.29 from CNY 955,141,269.85 year-over-year [51]. Shareholder Information - As of March 31, 2023, the total number of common shareholders was 69,209, with the largest shareholder, China National Chemical Corporation, holding 1,948,551,478 shares, representing 54.25% of total shares [27]. Research and Development - Research and development expenses increased to $246.71 million in Q1 2023, compared to $228.78 million in Q1 2022, reflecting a growth of 7.9% [42]. - The company has not disclosed any new product developments or technological advancements in the provided content [32]. Market Activity - There are no mentions of market expansion or mergers and acquisitions in the extracted data [32].

Financial Performance - The company's operating revenue increased by 8.25% year-on-year, reaching 87.45 billion RMB, despite challenges in the domestic market[6] - The net profit attributable to shareholders was ¥1.31 billion, a decrease of 39.15% year-on-year[24] - The net cash flow from operating activities was ¥3.41 billion, reflecting a significant increase of 156.34% compared to the previous year[24] - The company's total assets at the end of 2022 amounted to ¥70.26 billion, up 21.25% from the previous year[24] - The overall gross profit margin for the company decreased by 1.39 percentage points to 8.66%[6] - The company achieved operating revenue of 87.449 billion yuan, an increase of 6.667 billion yuan, with a growth rate of 8.25%[38] - The net profit attributable to shareholders was 1.311 billion yuan, a decrease of 843 million yuan, reflecting a decline of 39.15%[38] - The company achieved a total revenue of 87.449 billion RMB in 2022, representing an increase of approximately 18% compared to the previous year[166] Segment Performance - Revenue from the strategic emerging industries segment surged by 156.48% year-on-year, with a gross profit margin of 15.25%[6] - The revenue from the pharmaceutical health business was 4.59 billion RMB, with a gross profit margin of 6.47%, reflecting a 3.39% increase year-on-year[9] - The natural rubber business reported revenue of 18.12 billion RMB, with a gross profit margin of 5.11%, marking a 14.07% increase year-on-year[9] - The revenue from basic raw materials and intermediates increased significantly by 71.40% year-on-year, but the gross profit margin fell to 22.82%[6] - The high-performance materials business generated operating revenue of 632,394.5 million CNY in 2022, a decrease of 5.18% year-on-year[81] - The polymer additive business achieved revenue of 562,621.61 million CNY, representing a year-on-year growth of 30.21%[91] - The strategic emerging business recorded revenue of 83,187.61 million CNY in 2022, marking a significant year-on-year increase of 156.48%[100] Cost and Profitability - The gross profit margin for the chemical new materials segment decreased by 1.57 percentage points to 24.32%[6] - The gross profit margin for the high-performance materials segment decreased by 3.52 percentage points to 13.34% due to market price declines[6] - The company faced a decline in revenue from chemical materials marketing, which decreased by 7.75% year-on-year, with a gross profit margin of 3.86%[6] - The company's product mix sales accounted for 33% of total revenue, reflecting an increase in high-value-added business[106] Research and Development - Research and development investment reached 1.256 billion yuan, focusing on new chemical materials (55.8% of total R&D), with new product sales revenue increasing by 41% year-on-year to 9.01 billion yuan[36] - The company applied for 288 patents during the reporting period, enhancing its innovation capabilities and technology transfer[53] - The company has established four central research centers focusing on engineering plastics, high-performance fibers, polymer additives, and specialty resins to enhance core technology research[114] Market Position and Strategy - The company is focusing on technology innovation and strategic project planning to ensure stable operational performance amid market fluctuations[35] - The company is actively expanding its lithium battery materials business, including the establishment of a 3,000-ton lithium battery recycling pilot line[99] - The company aims to enhance its competitive position in the plastic additives sector, focusing on both rubber and plastic additives as dual core drivers of growth[89] - The company is positioned in a competitive landscape with a focus on intermediates, new materials, and polymer additives, serving clients in over 100 countries[181] Sustainability and HSE - The company aims to become a global leader in HSE, focusing on health, safety, and environmental sustainability[119] - The issuance of 3.5 billion RMB in sustainable bonds supports the company's commitment to carbon neutrality and ESG responsibilities[118] - The company is committed to green and clean production processes, continuously improving environmental protection measures[120] Financial Management - As of the end of 2022, the bank credit line reached 82.8 billion RMB, with a comprehensive financing cost of 3.52%[118] - The company issued a total of 131 million RMB in short-term financing bonds at an average interest rate of 1.83%[118] - Successfully raised 4.975 billion RMB through a private placement, achieving nearly 40% oversubscription[118] Economic Environment - The chemical industry faced significant price volatility, with major chemical product prices rising in the first half of 2022 before sharply declining in the second half[193] - Global oil prices surged above 120 USD per barrel in the first half of 2022, the highest since 2008, before stabilizing above 80 USD per barrel in the latter half[198] - The geopolitical conflicts led to a reduction in overseas production capacity, causing a shift in demand towards domestic chemical products[197]

Financial Performance - The company's operating revenue for Q3 2022 was ¥21,526,482,592.19, representing a 10.56% increase compared to ¥19,416,826,204.58 in the same period last year[8]. - Net profit attributable to shareholders was ¥315,441,479.35, a 21.01% increase from ¥263,803,066.99 year-on-year[8]. - The basic earnings per share increased to ¥0.11, up 37.5% from ¥0.08 in the previous year[8]. - The net profit attributable to shareholders for the first three quarters of 2022 was ¥1,289,781,591.26, a decrease of 46.36% compared to the previous year[11]. - The company reported a 27% increase in revenue and an 80% increase in net profit attributable to shareholders when excluding the impact of the sale of Jiangsu Yangnong Chemical Co., Ltd. shares in the previous year[11]. - The company's net profit attributable to shareholders increased to ¥7,892,172,730.32 from ¥6,872,919,520.27, marking a growth of around 14.8%[41]. - The company's net profit for the third quarter of 2022 was approximately CNY 2.03 billion, a decrease from CNY 6.61 billion in the same period of 2021, representing a decline of about 69%[48]. - Operating profit for the third quarter was CNY 2.69 billion, down from CNY 9.57 billion year-over-year, indicating a decrease of approximately 72%[48]. - The company reported a total comprehensive income of CNY 1.71 billion for the third quarter, down from CNY 6.34 billion in the previous year, marking a decline of approximately 73%[48]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥66,717,754,833.31, marking a 15.08% increase from ¥57,973,201,813.52 at the end of the previous year[10]. - The company's total liabilities grew to ¥45,489,722,905.80 from ¥38,043,780,010.74, indicating an increase of around 19.4%[41]. - Short-term borrowings increased significantly to ¥10,166,405,646.24 from ¥7,676,723,495.59, representing a rise of about 32.5%[39]. - Long-term borrowings also saw a substantial increase, reaching ¥12,791,087,031.39, up from ¥9,260,928,473.07, which is an increase of approximately 38.5%[39]. - The company's current assets totaled ¥21,452,836,253.27, with significant components including accounts receivable of ¥3,679,760,457.14 and inventory of ¥7,594,505,990.67[58]. - The total liabilities reached ¥38,043,780,010.74, with current liabilities accounting for ¥26,455,843,401.43, including short-term borrowings of ¥7,676,723,495.59[61]. Cash Flow and Investments - Net cash flow from operating activities significantly improved compared to the previous year due to enhanced operational efficiency[22]. - The net cash flow from operating activities for the first nine months of 2022 was CNY 2.69 billion, a significant recovery from a negative cash flow of CNY -2.05 billion in the same period of 2021[52]. - The company reported a net cash outflow from investing activities of CNY 6.95 billion for the first nine months of 2022, compared to a smaller outflow of CNY 178.53 million in the same period of 2021[52]. - The company raised CNY 46.28 billion through borrowings in the first nine months of 2022, compared to CNY 39.57 billion in the same period of 2021, indicating a growth of approximately 17%[53]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 69,090[24]. - China National Chemical Corporation held 54.23% of shares, making it the largest shareholder[24]. Operational Efficiency - The company is focused on enhancing operational efficiency and improving working capital turnover[22]. - The company has implemented new accounting standards affecting the recognition of revenue and costs related to trial sales of products[12]. Research and Development - Research and development expenses amounted to ¥702,361,361.76, slightly higher than ¥684,531,505.70 in the previous year, reflecting a year-over-year increase of approximately 2.4%[42].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥44.41 billion, an increase of 13.96% compared to ¥38.97 billion in the same period last year[19]. - The net profit attributable to shareholders for the first half of 2022 was ¥974.34 million, a decrease of 54.55% from ¥2.14 billion in the previous year[19]. - The net profit after deducting non-recurring gains and losses was ¥867.93 million, an increase of 44.46% compared to ¥600.82 million in the same period last year[19]. - The company's total assets reached ¥67.22 billion, reflecting a growth of 16.04% from ¥57.93 billion at the end of the previous year[19]. - The net assets attributable to shareholders increased by 5.38% to ¥12.87 billion from ¥12.22 billion at the end of the previous year[19]. - Basic earnings per share for the first half of 2022 were ¥0.35, down 55.13% from ¥0.78 in the same period last year[22]. - The diluted earnings per share were also ¥0.35, representing a decrease of 54.55% compared to ¥0.77 in the previous year[22]. - The weighted average return on net assets decreased by 8.61 percentage points to 8.04% from 16.65% in the same period last year[22]. - The company reported a net cash flow from operating activities of ¥1.38 billion, a significant improvement from a negative cash flow of ¥1.32 billion in the previous year[19]. - The company achieved a revenue of 44.413 billion RMB in the first half of the year, representing a year-on-year increase of 13.96%[45]. - The net profit attributable to shareholders reached 974 million yuan, with a non-recurring net profit of 868 million yuan, showing a year-on-year growth of 44.46%[45]. Production and Capacity Expansion - The company has successfully launched a 150,000 tons/year ECH production line in Lianyungang, which began stable operations in Q1 2022, enhancing its leading position in the domestic ECH market[32]. - The company has a total epoxy resin production capacity of 350,000 tons/year following the trial production of an 180,000 tons/year epoxy resin project in Lianyungang in Q2 2022, solidifying its status as a leading player in the domestic epoxy resin market[33]. - The company’s high-performance materials segment includes a successful launch of a 40,000 tons/year nylon 66 project and a 25,000 tons/year intermediate J project in Q2 2022, marking significant progress in its materials industry[33]. - The company has established itself as a global leader in rubber additives, with the 25,000 tons/year rubber antioxidant factory in Thailand commencing operations in Q2 2022[34]. - The company has established an annual production capacity of 10,000 tons for ternary cathode materials in the lithium battery sector, with stable operations[38]. - The company has a total of six major construction projects, including a 20,000-ton annual production project for dichlorobenzene and trichlorobenzene, which was approved in October 2017 and began trial production in November 2019[107]. - The company has an annual production capacity of 180,000 tons of epoxy resin and supporting engineering projects, with trial production approved on June 15, 2022[110]. - The company has a total of 20,000 tons per year capacity for epoxy resin production, with relevant environmental assessments completed[134]. Strategic Focus and Market Position - The company is focusing on expanding its polymer additives business, with ongoing projects in Lianyungang aimed at enhancing its production capabilities[34]. - The company is navigating a challenging economic environment, with pressures from domestic COVID-19 outbreaks and international conflicts impacting demand for chemical products[31]. - The company is committed to innovation and sustainability, aiming to provide comprehensive additive solutions that support the development of new materials[34]. - The company’s strategic focus includes enhancing its existing businesses in ECH, epoxy resins, and polymer additives while pursuing growth in high-potential markets like nylon 66 and ABS[31]. - The company has signed contracts exceeding 19.9 billion yuan for major strategic projects, including carbon three and promoting agent projects[42]. - The company has actively expanded its overseas market presence and optimized production strategies in response to external challenges such as the pandemic and geopolitical tensions[45]. Environmental Management and Compliance - The company emphasizes HSE (Health, Safety, and Environment) as a core competitive advantage, aiming for continuous improvement and sustainable development[83]. - The company has not experienced any sudden environmental pollution incidents in the first half of 2022[84]. - The company has implemented strict environmental management measures for construction projects, ensuring compliance with environmental assessments and monitoring[85]. - The company has been recognized with multiple "Green Factory" awards from various authorities, reflecting its commitment to environmental protection[84]. - The company achieved a wastewater discharge volume of 35,549.58 tons, with COD levels at 252.7 mg/L, significantly below the standard limit of 500 mg/L[89]. - The company implemented a comprehensive wastewater treatment process, achieving a low discharge concentration that meets regulatory requirements[89]. - The company reported a SO2 emission level of 6.85 mg/L, well below the standard limit of 200 mg/L, and NOx emissions at 26.24 mg/L, also below the 200 mg/L threshold[96]. - The company has actively engaged in the recycling of hazardous waste, monitoring its lifecycle from generation to disposal[89]. - The company has conducted emergency response drills and maintains adequate material reserves for environmental emergencies[89]. - The company has successfully implemented VOCs deep treatment projects, further reducing unorganized emissions[98]. - The company has established a comprehensive monitoring system for hazardous waste, ensuring compliance with legal disposal requirements[89]. - The company has been operating under a valid pollution discharge permit, with the permit number 91321081765862024H001P[89]. - The company has conducted regular soil monitoring to prevent soil pollution around production and storage areas[105]. - The company has taken measures to harden and prevent seepage in production areas, storage tanks, and wastewater treatment facilities[105]. - The company has implemented a comprehensive pollution control project to manage emissions effectively[173]. - The company has established a valid pollution discharge permit, ensuring compliance with environmental regulations[139]. Research and Development - The company has made significant advancements in R&D, with successful industrialization of ECH and PA66, and established four central research centers for core technology research[39]. - The company is actively engaged in the development of new technologies and products to enhance market expansion and operational efficiency[110]. - The company has implemented a comprehensive VOCs management strategy, including the installation of two fixed-source online monitoring facilities and five boundary monitoring facilities[120]. - The company has developed a new clean production project with an annual capacity of 80,000 tons of rubber antioxidant and 100,000 tons of intermediates[152]. - The company has established a network for automatic monitoring of emissions, ensuring compliance with environmental standards[191]. Financial Strategies and Investments - The bank credit scale has expanded to 73.7 billion yuan, with an average financing interest rate as low as 3.35%[42]. - The company has implemented a multi-channel financing approach, successfully issuing 35 billion yuan in sustainable bonds to support its carbon neutrality commitments[42]. - The company has increased investments in subsidiaries by ¥653,350,002.00 during the reporting period[63]. - The company issued ¥3.5 billion in sustainable-linked bonds, significantly increasing its bond payables by 444.51% to ¥4.35 billion[55]. - The company has restricted cash balances of ¥535,561,707.82 due to ownership or usage rights limitations[61]. - The company has pledged accounts receivable of ¥447,254,427.10 as collateral for bank loans[61]. - The total value of pledged inventory is ¥1,029,144,148.78, and fixed assets pledged amount to ¥1,506,621,836.72[61]. Hazardous Waste Management - The company has a total of 5.82 tons of non-methane total hydrocarbons emitted, with a target limit of 80%[100]. - The company has achieved zero detection levels for several hazardous emissions, including nitrobenzene and aniline[100]. - The company is actively engaged in the disposal of hazardous waste through partnerships with specialized waste disposal companies[102]. - The company has a total of 106.51 tons of hazardous waste from trichlorobenzene tar, with all waste properly disposed of[116]. - The company has conducted regular soil and groundwater testing to ensure environmental compliance[149]. - The company has established measures to prevent soil pollution, including impermeable treatment for storage areas and regular soil environment testing[158]. - The company has implemented full lifecycle monitoring of hazardous waste, including generation, collection, storage, transportation, and disposal[158]. - The company has a total of 34.471 tons of hazardous waste (organic solvents) produced this year, all disposed of through incineration[169]. - The company has a total of 55.713 tons of nitrobenzene tar generated and 67.683 tons disposed of through incineration[181].

Financial Performance - The company's revenue for Q1 2022 was CNY 18.84 billion, an increase of 8.17% compared to CNY 17.42 billion in the same period last year[6]. - Net profit attributable to shareholders for Q1 2022 was CNY 394.05 million, representing a growth of 30.33% from CNY 302.36 million in the previous year[6]. - The net profit after deducting non-recurring gains and losses was CNY 315.22 million, a decrease of 8.80% compared to CNY 345.64 million in the same period last year[9]. - Basic earnings per share for Q1 2022 were CNY 0.14, up 27.27% from CNY 0.11 in the same period last year[9]. - The company reported a 35% increase in revenue and a 66% increase in net profit attributable to shareholders when excluding the data from Jiangsu Yangnong Chemical Co., Ltd. from the previous year[9]. - The company reported a total comprehensive income of ¥672,075,835.44 for Q1 2022, down from ¥824,380,154.97 in Q1 2021, a decline of 18.43%[40]. - The net profit for Q1 2022 was a loss of ¥47,137,656.98, compared to a loss of ¥19,845,215.44 in Q1 2021, indicating a worsening performance[55]. Assets and Liabilities - The company's total assets increased by 12.63% to CNY 65.30 billion from CNY 57.97 billion at the end of the previous year[9]. - The company's total liabilities increased to ¥44,705,081,641.85 in Q1 2022, compared to ¥38,043,780,010.74 in Q1 2021, marking a rise of 17.55%[33]. - The total equity attributable to shareholders reached ¥12,643,357,270.71 in Q1 2022, up from ¥12,249,256,509.15 in Q1 2021, indicating an increase of 3.22%[33]. - The company's total assets reached ¥65,297,376,652.50 in Q1 2022, compared to ¥57,973,201,813.52 in Q1 2021, representing an increase of 12.56%[33]. - The total liabilities of the company stood at ¥35,716,787,873.50, with current liabilities accounting for ¥26,455,843,401.43[64]. Cash Flow - Cash flow from operating activities showed a significant improvement, with a net cash outflow of CNY 974.72 million, compared to a net outflow of CNY 2.55 billion in the previous year[9]. - The net cash flow from operating activities decreased primarily due to revenue growth and timely capital recovery[20]. - Cash flow from investment activities increased due to higher expenditures on engineering projects[20]. - Net cash flow from operating activities was negative CNY 974,721,203.68, an improvement from negative CNY 2,548,553,447.67 in Q1 2021[41]. - Cash inflow from financing activities was CNY 12,440,831,070.08, compared to CNY 11,448,305,212.33 in Q1 2021, reflecting an 8.7% increase[43]. - The company's cash flow from operating activities in Q1 2022 was ¥1,244,498,429.13, compared to ¥786,220,731.70 in Q1 2021, representing an increase of approximately 58.2%[55]. Current Assets and Inventory - Total current assets as of March 31, 2022, amounted to CNY 27.29 billion, up from CNY 21.45 billion at the end of 2021, representing a growth of approximately 27.5%[27]. - Cash and cash equivalents increased to CNY 4.88 billion from CNY 2.98 billion year-on-year, reflecting a growth of approximately 63.4%[27]. - Accounts receivable rose to CNY 5.13 billion, compared to CNY 3.68 billion in the previous year, indicating a growth of approximately 39.4%[27]. - Inventory increased to CNY 9.88 billion from CNY 7.59 billion, representing a growth of approximately 30.2%[27]. - The total current assets amounted to CNY 8,782,442,016.24, compared to CNY 6,334,380,050.60 in the previous year, indicating a 38.7% increase[48]. Expenses - Total operating costs for Q1 2022 were ¥18,027,272,296.67, up from ¥16,152,401,685.52 in Q1 2021, reflecting a growth of 11.56%[37]. - Research and development expenses for Q1 2022 were ¥228,777,303.03, slightly up from ¥223,415,726.06 in Q1 2021, showing a growth of 2.03%[39]. - Financial expenses in Q1 2022 amounted to ¥148,495,257.64, significantly higher than ¥10,303,540.86 in Q1 2021, reflecting a substantial increase[39]. - Operating expenses for Q1 2022 included sales expenses of ¥23,821,682.68 and management expenses of ¥81,820,363.79, which were higher than the previous year's figures[53]. - The financial expenses for Q1 2022 were ¥93,012,383.66, significantly higher than ¥16,781,020.84 in Q1 2021, marking an increase of about 453.5%[53]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 74,428, with the largest shareholder, China National Chemical Corporation, holding 54.21%[21]. - The company's total equity decreased to ¥9,913,681,872.44 in Q1 2022 from ¥9,956,417,861.88 in Q1 2021, showing a decline of about 0.4%[53].

Financial Performance - The company's revenue for Q1 2022 was CNY 18.84 billion, an increase of 8.17% compared to CNY 17.42 billion in the same period last year[6]. - Net profit attributable to shareholders was CNY 394.05 million, representing a growth of 30.33% from CNY 302.36 million year-on-year[6]. - The net profit after deducting non-recurring gains and losses was CNY 315.22 million, a decrease of 8.80% compared to CNY 345.64 million in the previous year[9]. - Basic earnings per share increased to CNY 0.14, up 27.27% from CNY 0.11 in the same period last year[9]. - Total operating revenue for Q1 2022 reached ¥18,843,657,869.58, an increase of 8.14% compared to ¥17,420,638,414.38 in Q1 2021[37]. - Net profit for Q1 2022 was ¥645,248,535.38, a decrease of 30.77% from ¥930,473,929.03 in Q1 2021[40]. - The total comprehensive income for Q1 2022 was ¥672,075,835.44, down from ¥824,380,154.97 in Q1 2021, reflecting a decline of 18.43%[40]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 65.30 billion, reflecting a 12.63% increase from CNY 57.97 billion at the end of the previous year[9]. - The company's total liabilities increased to ¥44,705,081,641.85 in Q1 2022, compared to ¥38,043,780,010.74 in Q1 2021, marking a rise of 17.55%[33]. - The company's total assets reached ¥65,297,376,652.50 in Q1 2022, compared to ¥57,973,201,813.52 in Q1 2021, an increase of 12.56%[33]. - The total liabilities increased to ¥19,700,809,870.90 in Q1 2022 from ¥17,189,864,146.47 in Q1 2021, reflecting a growth of approximately 14.6%[53]. - The total liabilities amounted to ¥35,716,771,875.50, reflecting a stable financial position compared to the previous year[63]. Cash Flow - Cash flow from operating activities was negative at CNY -974.72 million, an improvement from CNY -2.55 billion in the same period last year[9]. - Cash inflow from operating activities totaled CNY 19,567,889,448.48 in Q1 2022, up from CNY 15,358,884,906.44 in Q1 2021, marking an increase of 27.5%[41]. - The company reported a net cash outflow from operating activities, primarily due to revenue growth and timely capital recovery[20]. - Cash flow from investing activities showed a net outflow of CNY -2,488,521,745.03 in Q1 2022, compared to a net inflow of CNY 797,291,916.10 in Q1 2021[43]. - Cash flow from financing activities resulted in a net inflow of CNY 5,360,648,049.85 in Q1 2022, an increase from CNY 4,762,936,966.84 in Q1 2021, reflecting a growth of 12.5%[43]. - The net cash flow from operating activities for Q1 2022 was ¥6,649,241.12, a significant improvement compared to a negative cash flow of ¥139,168,953.88 in Q1 2021[58]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 2,765,166,472 shares[21]. - China National Chemical Corporation holds 54.21% of the shares, totaling 1,498,885,610 shares[21]. - Shareholders' equity totaled ¥20,592,295,010.65 in Q1 2022, up from ¥19,929,421,802.78 in Q1 2021, indicating an increase of 3.33%[33]. - The total equity attributable to minority shareholders was approximately ¥7.68 billion[67]. Expenses - Total operating costs for Q1 2022 were ¥18,027,272,296.67, up from ¥16,152,401,685.52 in Q1 2021, reflecting a growth of 11.56%[37]. - Research and development expenses for Q1 2022 were ¥228,777,303.03, slightly up from ¥223,415,726.06 in Q1 2021, showing a growth of 2.03%[39]. - The company reported a financial expense of ¥148,495,257.64 in Q1 2022, significantly higher than ¥10,303,540.86 in Q1 2021[39]. - Financial expenses surged to ¥93,012,383.66 in Q1 2022, compared to ¥16,781,020.84 in Q1 2021, indicating a significant increase[53]. Other Income and Changes - The company reported a significant increase in other income, which rose by 41.61% to CNY 0.54 billion due to increased government subsidies[17]. - The company experienced a 63.65% increase in cash and cash equivalents, attributed to funds raised from issuing corporate bonds[17]. - The fair value change loss for Q1 2022 was CNY 0.27 billion, a decrease compared to the same period last year, amounting to CNY -0.7896 billion[20]. - Operating income from non-operating activities increased to CNY 0.34 billion in Q1 2022, attributed to new energy-saving indicator transfer income[20].

Financial Performance - The company achieved a revenue of RMB 80.648 billion in 2021, representing a year-on-year increase of 48.9%[26] - The net profit attributable to shareholders reached RMB 2.175 billion, with a remarkable year-on-year growth of 608.9%[26] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 565 million, showing a year-on-year increase of 45649.01%[26] - The company’s basic earnings per share were RMB 0.78, indicating a significant increase compared to the previous year[20] - The company's operating revenue for 2021 was CNY 80.65 billion, an increase of 48.90% compared to CNY 54.16 billion in 2020[152] - The net profit attributable to shareholders for 2021 reached CNY 2.18 billion, a significant increase of 608.90% from CNY 306.87 million in 2020[152] - The weighted average return on equity for 2021 was 17.77%, an increase of 15.63 percentage points from 2.14% in 2020[153] - The company reported a net cash flow from operating activities of CNY 1.37 billion, a decrease of 46.67% compared to CNY 2.58 billion in 2020[152] - The company’s diluted earnings per share for 2021 was CNY 0.77, reflecting a 755.56% increase from CNY 0.09 in 2020[153] - The operating costs for 2021 were 72.48 billion RMB, which is a 52.32% increase compared to the previous year[197] Investment and Expenditure - The company’s capital expenditure on construction projects amounted to RMB 11.394 billion, reflecting a growth of 115% compared to the beginning of the year[27] - Research and development investment totaled RMB 1.485 billion, marking a year-on-year increase of 26.14%[28] - R&D investment reached 1.485 billion RMB in 2021, a year-on-year increase of approximately 26.14%, with 243 patents applied for, including 165 invention patents[43] - The company implemented 29 key energy-saving projects, saving 27,500 tons of standard coal and reducing carbon dioxide emissions by 71,500 tons in 2021[42] - The company has established a multi-dimensional incentive mechanism to promote technological innovation and the industrialization of technological achievements[120] Strategic Focus and Business Development - The company is focusing on strategic projects in chemical new materials, lithium batteries, and polymer additives, with ongoing construction projects in these areas[27] - The company’s annual report highlights a focus on enhancing core competitiveness in key industrial chains, including aramid and lithium battery materials[37] - The company aims to strengthen its position in the green low-carbon and technological innovation sectors, aligning with the "dual carbon" goals[41] - The polymer additive industrial chain expansion is a key strategic move, with ongoing construction and equipment procurement for the first phase project[33] - The company is actively exploring carbon neutrality and carbon trading opportunities to enhance business collaboration and achieve new performance breakthroughs[109] Market Position and Product Development - The chemical new materials business generated revenue of RMB 15.7 billion, with a year-on-year increase of 74.64%[20] - Sales revenue from new products was approximately RMB 6.37 billion, with a year-on-year growth of about 14.3%[28] - The company’s epoxy resin production capacity stands at 350,000 tons per year, maintaining a leading market position domestically and globally[55] - The company’s ABS production capacity stands at 170,000 tons per year, capturing 40% of the European specialty ABS market through its subsidiary Elix Polymers[71] - The company is expanding its product portfolio with the construction of a new 180,000 tons per year epoxy resin project, which has entered the commissioning phase[69] - The company is addressing the supply gap in high-end epoxy resins, with an annual consumption shortfall exceeding 300,000 tons in China[83] - The polymer additive business achieved revenue of 432,102.27 million RMB, representing a year-on-year growth of 80.63%[92] - The strategic emerging business generated revenue of 30,593.07 million RMB, with a remarkable year-on-year increase of 447.63%[101] Challenges and Market Conditions - The company faced significant challenges due to rising raw material prices, with coal prices reaching historical highs of around 2500 RMB per ton[179] - The global shipping costs surged, impacting the logistics of chemical products due to increased demand and limited shipping capacity[187] - The rapid development of new energy sectors, with a 159.5% increase in new energy vehicle production, is expected to drive industry upgrades[188] Safety and Environmental Management - Sinochem International has developed a comprehensive HSE management system, resulting in 546 standardized practices to enhance safety and environmental management[127] - The company has trained 126 safety managers, including 52 senior safety managers, to implement advanced safety management concepts[128] - A total of 17 enterprises and one research institution have passed the "Five-Star Factory"/"Five-Star Research Institute" certification, promoting overall HSE management improvement[129] - The Total Recordable Case Frequency (TRCF) has shown continuous improvement, indicating enhanced safety performance[129] Financing and Credit - The bank credit line reached 68.4 billion RMB by the end of 2021, with an average financing interest rate of 2.92%[123] - In 2021, Sinochem International signed a total of over 19.7 billion RMB in syndicated loans for major strategic projects[123] - The company issued five batches of short-term financing bonds with an average interest rate of 2.4% and raised 700 million RMB in perpetual bonds and 800 million RMB in corporate bonds[123] - The company has maintained stable ratings: China Chengxin AAA, Moody's Baa1, S&P BBB+, and Fitch A-[124]

Financial Performance - The company's operating revenue for Q3 2021 reached ¥19,416,826,204.58, a 49.85% increase compared to ¥12,850,611,976.25 in the same period last year[9] - Net profit attributable to shareholders was ¥263,803,066.99, representing a 132.06% increase from ¥107,802,956.12 year-on-year[9] - The basic earnings per share (EPS) for the quarter was ¥0.08, doubling from ¥0.04 in the previous year[9] - The company experienced a significant year-to-date net profit increase of 1,517.74%, rising to ¥2,414,685,109.76 from ¥128,014,662.71 in the previous year[9] - The operating profit surged to ¥9,579,989,000.20, compared to ¥1,529,085,040.75 in the prior period, indicating a growth of about 527%[43] - The total profit before tax was ¥9,587,992,622.75, significantly higher than ¥1,558,878,661.28 from the previous year, showing an increase of approximately 516%[43] - The total comprehensive income for the current period was ¥6,357,194,298.82, compared to ¥1,193,729,133.36 in the previous period, indicating a growth of approximately 431%[46] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥59,612,799,078.61, reflecting a 6.57% increase from ¥55,936,902,284.94 at the end of the previous year[11] - Current assets totaled ¥26.19 billion as of September 30, 2021, up from ¥24.49 billion at the end of 2020, reflecting a growth of approximately 7%[32] - Total liabilities increased to ¥37.55 billion in Q3 2021 from ¥27.94 billion in 2020, reflecting a growth of approximately 34.5%[37] - The company's total assets reached ¥59.61 billion as of September 30, 2021, up from ¥55.94 billion at the end of 2020, indicating a growth of approximately 6.4%[35] - Total liabilities amounted to $21.57 billion, slightly up from $21.52 billion in the previous period[52] Cash Flow - The net cash flow from operating activities for the year-to-date was negative at -¥2,040,008,625.63, compared to positive cash flow of ¥943,338,317.97 in the same period last year[9] - The net cash flow from operating activities was -$2.04 billion, a decrease from $1.03 billion in the previous period[49] - Total cash outflow from operating activities reached $61.23 billion, compared to $39.50 billion last year, indicating a significant increase[49] - Cash inflow from investment activities totaled $11.24 billion, up from $3.27 billion in the previous year[49] - The net cash flow from investment activities was -$177.13 million, an improvement from -$1.80 billion year-over-year[49] - The ending cash and cash equivalents balance was $3.31 billion, down from $9.93 billion at the end of the previous period[49] Equity and Retained Earnings - The total equity attributable to shareholders increased to ¥14,398,253,777.09, an 11.10% rise from ¥12,959,353,124.15 at the end of the previous year[11] - The company's retained earnings increased to ¥7.15 billion in Q3 2021 from ¥4.89 billion in 2020, marking a growth of about 46.3%[37] - The company’s total equity increased to $34.55 billion, reflecting a stable financial position despite cash flow challenges[52] Investment and Expenses - Investment income surged by 3,824.98% due to the disposal of a subsidiary[20] - Research and development expenses increased to ¥684,059,189.93, up from ¥626,414,914.95, representing a rise of approximately 9%[43] - The company reported a decrease in financial expenses to ¥255,437,150.31 from ¥355,053,302.34, a reduction of about 28%[43] - The income tax expense for the current period was ¥2,961,831,481.85, compared to ¥254,810,775.11 in the previous period, reflecting a significant increase[43]